Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8696483 | Archives of Oral Biology | 2018 | 6 Pages |
Abstract
We identify that miR-186 serves as a tumor suppressor in OSCC. Downregulation of this microRNA may lead to a higher expression of oncogenic factor SHP2, which leads to activation of growth promoting signaling. Thus, miR-186 may be a novel and effective therapeutic agent for the treatment of OSCC.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Zhen Cai, Xiu-Yan Hao, Feng-Xin Liu,